Updated guidance on metal-on-metal (MoM) hip replacements
The Medicines and Healthcare products Regulatory Agency (MHRA) as a precautionary measure has issued updated guidance for healthcare professionals who manage patients implanted with metal-on-metal hip replacements. You can find out more here:
Previous guidance was issued to ensure appropriate follow-up to monitor the potential for the already well-known risks of soft-tissue reactions. This updated guidance replaces the previous advice provided in 2012.